Literature DB >> 8530141

The C/EBP family of transcription factors.

A Wedel1, H W Ziegler-Heitbrock.   

Abstract

The C/EBP proteins form a family of transcription factors with at least seven members. These proteins consist of three structural components which include a C-terminal leucine-zipper, a basic DNA-binding region and a N-terminal transactivating region. Dimerization through the leucine-zipper leads to formation of homo- and heterodimers which then bind with their two basic regions to often non-symmetric DNA-sequences in the promoter/enhancer regions of a variety of genes. Expression of C/EBP is prominent in adipocytes, hepatocytes and monocytes/macrophages, and here these proteins are involved in tissue-specific gene expression. Target genes for C/EBP include those for acute phase response genes in liver cells and for cytokine genes in monocytes/macrophages. Therefore, intervention at the level of C/EBP transcription factors may prove effective in controlling immune response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530141     DOI: 10.1016/s0171-2985(11)80541-3

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  57 in total

1.  Expression, DNA-binding specificity and transcriptional regulation of nuclear factor 1 family proteins from rat.

Authors:  S Osada; T Matsubara; S Daimon; Y Terazu; M Xu; T Nishihara; M Imagawa
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

2.  Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.

Authors:  S B Kennett; A J Udvadia; J M Horowitz
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  CCAAT/enhancer binding protein-δ expression by dendritic cells regulates CNS autoimmune inflammatory disease.

Authors:  Vicky W W Tsai; Mohammad G Mohammad; Ornella Tolhurst; Samuel N Breit; Paul E Sawchenko; David A Brown
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

4.  The CCAAT/enhancer binding protein beta is a critical regulator of steroid-induced mitotic expansion of uterine stromal cells during decidualization.

Authors:  Wei Wang; Quanxi Li; Indrani C Bagchi; Milan K Bagchi
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

5.  Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells.

Authors:  C Schwartz; P Catez; O Rohr; D Lecestre; D Aunis; E Schaeffer
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  A novel transcriptional regulatory region within the core promoter of the hepatocyte growth factor gene is responsible for its inducibility by cytokines via the C/EBP family of transcription factors.

Authors:  J G Jiang; R Zarnegar
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

7.  High bone marrow fat in patients with Cushing's syndrome and vertebral fractures.

Authors:  Francesco Ferraù; Salvatore Giovinazzo; Erika Messina; Agostino Tessitore; Sergio Vinci; Gherardo Mazziotti; Andrea Lania; Francesca Granata; Salvatore Cannavò
Journal:  Endocrine       Date:  2019-08-02       Impact factor: 3.633

8.  Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes.

Authors:  W Briest; B Rassler; A Deten; M Leicht; R Morwinski; D Neichel; G Wallukat; T Ziegelhöffer; H-G Zimmer
Journal:  Pflugers Arch       Date:  2003-05-06       Impact factor: 3.657

Review 9.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

10.  Lack of CCAAT enhancer binding protein beta (C/EBPbeta) in uterine epithelial cells impairs estrogen-induced DNA replication, induces DNA damage response pathways, and promotes apoptosis.

Authors:  Cyril Ramathal; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.